Stock Rich List
#2739 on the rich list of 14,644 insiders

Reshma Kewalramani

CEO & President at Vertex Pharmaceuticals; Director at Ginkgo Bioworks Holdings. Based in Boston, Massachusetts.

$45.1M
in disclosed stock, −$1.4M (−2.94%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
2739th of 14,644
Companies held
2
Largest holding
VRTX, 99.9% of total
Latest SEC filing
Nov 6, 2026

What the $45.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Vertex Pharmaceuticals VRTX
Common Stock
Directly86,471$520.66$45.0M99.9%Form 4, Nov 6, 2026
Ginkgo Bioworks Holdings DNA
Class A Common Stock
Directly4,650
split-adjusted
$8.20$38K0.1%Form 4, Jun 12, 2024

Share counts are the amounts Reshma Kewalramani reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 6, 2026SoldVRTX11,866$531.53$6.3MView
Feb 27, 2026SoldVRTX3,278$488.27$1.6MView
Feb 27, 2026SoldVRTX2,510$487.13$1.2MView
Feb 27, 2026SoldVRTX240$482.84$116KView
Feb 27, 2026SoldVRTX120$481.50$58KView
Feb 27, 2026SoldVRTX400$479.75$192KView
Feb 27, 2026SoldVRTX460$489.32$225KView
Feb 27, 2026SoldVRTX1,725$496.95$857KView
Feb 27, 2026SoldVRTX5,995$496.16$3.0MView
Feb 27, 2026SoldVRTX2,725$490.54$1.3MView
Feb 27, 2026SoldVRTX949$491.30$466KView
Feb 27, 2026SoldVRTX2,520$493.29$1.2MView
Feb 27, 2026SoldVRTX3,498$494.33$1.7MView
Feb 27, 2026SoldVRTX15,580$495.38$7.7MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2736Edward Meyercord
PRESIDENT AND CEO, Extreme Networks. Morrisville, NC
$45.1M−$305K (−0.67%)
2737Raymond J. Lane
Director, Hewlett Packard Enterprise. Spring, TX
$45.1M−$288K (−0.64%)
2738Robert H. Adcock
Director, Home BancShares. Conway, AR
$45.1M−$930K (−2.02%)
2739Reshma Kewalramani
CEO & President, Vertex Pharmaceuticals. Boston, MA
$45.1M−$1.4M (−2.94%)
2740Leigh Ann Pusey
EVP, Corp. Affairs & Comm., Eli Lilly and. Indianapolis, IN
$45.1M−$987K (−2.14%)
2741Joshua E. Prime
Director, Levi Strauss &. San Francisco, CA
$45.0M−$996K (−2.16%)
2742Holger Blankenstein
EVP Airline, Controladora Vuela Compañía de Aviación, S.A.B. de C.V.
$45.0M−$1.3M (−2.88%)

Other Vertex Pharmaceuticals insiders

All VRTX insiders

Questions

How much stock does Reshma Kewalramani own?

Reshma Kewalramani holds $45,060,121 in listed stock based on SEC filings and current prices, mostly Vertex Pharmaceuticals (VRTX). That ranks 2739th on the Stock Rich List.

Is this Reshma Kewalramani's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Reshma Kewalramani last buy or sell stock?

The most recent open-market trade on file is a sale of 11,866 VRTX shares on Nov 6, 2026 at $531.53.